Inflammasomes are protein signaling complexes of immune-stromal cells and tumor cells that are in response to damage- and pathogen-associated molecular patterns (DAMPs and PAMPs) and trigger the release of inflammatory cytokines such as interleukin-1β (IL-1β) to participate in immune defense [5]. Here, IL1B is linked to neoplasm.